1,053 results on '"van den Berg, Anke"'
Search Results
2. Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR
3. Inhibition of the glutamate-cysteine ligase catalytic subunit with buthionine sulfoximine enhances the cytotoxic effect of doxorubicin and cyclophosphamide in Burkitt lymphoma cells
4. Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA
5. A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics
6. Proliferation-promoting roles of linear and circular PVT1 are independent of their ability to bind miRNAs in B-cell lymphoma
7. A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments
8. Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
9. Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP
10. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes
11. Obituary—Pieter Van Vlierberghe (1980–2022)
12. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas
13. Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature
14. Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis
15. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype
16. Microenvironment, Cross-Talk, and Immune Escape Mechanisms
17. Abstracts from the 3rd Conference on Aneuploidy and Cancer: Clinical and Experimental Aspects
18. Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC
19. Long Non-coding RNAs in the Development and Maintenance of Lymphoid Malignancies
20. Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma
21. Molecular imaging in lymphoma beyond 18F-FDG-PET: understanding the biology and its implications for diagnostics and therapy
22. Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.
23. Elevated serum TARC levels precede classic Hodgkin lymphoma diagnosis by several years
24. Inhibition of the glutamate-cysteine ligase catalytic subunit with buthionine sulfoximine enhances the cytotoxic effect of doxorubicin and cyclophosphamide in Burkitt lymphoma cells
25. Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
26. Targeting the Microenvironment in Hodgkin Lymphoma: Opportunities and Challenges
27. CRISPR/Cas9 screen for genome‐wide interrogation of essential MYC‐bound E‐boxes in cancer cells
28. Microenvironment, Cross-Talk, and Immune Escape Mechanisms
29. Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells
30. Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics
31. Long non‐coding RNAs associated with transcriptomic signatures and treatment outcome in diffuse large B‐cell lymphoma
32. NGS-Based High-Throughput Screen to Identify MicroRNAs Regulating Growth of B-Cell Lymphoma
33. Microenvironment, Crosstalk, and Immune Escape Mechanisms
34. Supplementary references from Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
35. Data from A Novel Risk Locus at 6p21.3 for Epstein–Barr Virus-Positive Hodgkin Lymphoma
36. Supplementary Table S3 from Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
37. Supplementary Figure 1 from Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
38. Supplementary Tables S1- S6 and Supplementary Figure S1 from A Novel Risk Locus at 6p21.3 for Epstein–Barr Virus-Positive Hodgkin Lymphoma
39. Meet Our Regional Editor
40. Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell–Specific Long Noncoding RNAs
41. Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell Carcinoma
42. Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
43. Targeting the Microenvironment in Hodgkin Lymphoma: Opportunities and Challenges
44. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma
45. Case report: TP53 and RB1 loss may facilitate the transformation from lung adenocarcinoma to small cell lung cancer by expressing neuroendocrine markers
46. Outcome of Transformed Marginal Zone Lymphoma: A Population Based Study
47. Tumor Microenvironment Composition Correlates with Quantitative 18F-FDG PET-CT Features and Serum TARC in Patients with Relapsed or Refractory Hodgkin Lymphoma
48. Detection of Cell Free Tumor DNA in Plasma of Patients with Large B-Cell Lymphoma of the Sanctuary Sites By Digital Droplet PCR
49. Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival
50. Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.